Beyond Weight Loss: GLP-1 Agonists and Alcohol Use Disorder

In this episode, we explore groundbreaking Swedish research on GLP-1 receptor agonists as a potential new treatment for alcohol use disorder. Could diabetes medications like semaglutide revolutionize addiction treatment where traditional therapies have fallen short?
Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D.
• Learn more about our membership here
• Earn 0.5 CME: Quick Take Vol. 72
• Which Antidepressants Cause the Most Weight Gain?